Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- moshe yeshurun
- Target Recruit Count
- 116
- Registration Number
- NCT04756622
Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Phase 2
- Conditions
- Acute-graft-versus-host Disease
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2015-03-19
- Lead Sponsor
- moshe yeshurun
- Target Recruit Count
- 10
- Registration Number
- NCT02392780
- Locations
- 🇮🇱
Davidof Cancer Center, Beilinson hospital, Rabin medical center, Petach Tikva, Israel
Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation
Phase 2
- Conditions
- Pediatric Patients Undergoing Allogeneic Cord Blood Transplantation.
- Interventions
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2015-06-16
- Lead Sponsor
- moshe yeshurun
- Target Recruit Count
- 20
- Registration Number
- NCT01940562
- Locations
- 🇮🇱
Hadassah hospital, Jerusalem, Israel
🇮🇱Schneider Children's Medical Center of Israel, Petah Tikva, Israel
News
No news found